Rispenzepine is a selective muscarinic receptor antagonist targeting M1 and M3 receptor subtypes; it inhibits cholinergic contractile responses in human and guinea pig trachea by blocking M1/M3 receptors; it significantly enhances acetylcholine (ACh) release in guinea pig trachea; it shows potent inhibitory activity against electrically evoked cholinergic contractions with a pD2 value of 7.31 ± 0.15.